An anti-inflammatory drug currently prescribed for arthritis and pain can prevent formation of precancerous growths in the colon and rectum, two analyses suggest. The drug might be especially valuable for people at high risk of developing these kinds of polyps, the data show.
However, regulatory clearance of the drug, called celecoxib, for cancer prevention is far from assured. Two nearly identical trials began in 1999 and 2001 but were stopped in 2004 when more than the expected number of participants developed heart problems while taking the drug, a COX-2 inhibitor.
Pfizer, which markets the drug under the name Celebrex, funded one of the two trials. Since 2005, the company has been required to sell celecoxib with a warning label about its heart risks.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.